Taking place at Farnborough International Exhibition Centre on 4th – 6th February 2025, it is the UK’s largest annual ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

SIGA Technologies has gained Japanese regulatory approval for TEPOXX (tecovirimat) 200mg capsules, known as TPOXX in the US, ...

SIGA Technologies (SIGA) stock gains as Japan approves antiviral Tepoxx as a treatment for orthopoxviruses including mpox.

Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal ...

(RTTNews) - SIGA Technologies, Inc. (SIGA), Thursday announced that its tecovirimat 200 mg capsules, traded as TEPOXX, has secured regulatory approval in Japan for the treatment of smallpox ...

SIGA Technologies (NASDAQ:SIGA) announced Thursday that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approved its antiviral product Tepoxx (tecovirimat) for the treatment of ...

State Street Corp trimmed its position in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 2.8% in the third quarter, ...

The SIGA Entity Portal was designed to streamline the operations of SEs by automating processes, centralising reports and financial data and delivering real-time insights.